Zepbound, from Eli Lilly, is a prescription injection for chronic weight management in adults with obesity or overweight plus a weight-related condition. It works by activating GLP-1 and GIP receptors to reduce appetite and food intake. Administered weekly, it helps patients achieve significant, sustainable weight loss when paired with diet and exercise.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends